Loncastuximab tesirine CAS No.1879918-31-6
Loncastuximab tesirine CAS No.1879918-31-6
| Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
|---|---|---|---|---|
| R-R-1956 | 100μg | 810.00 | + Add to cart |
|
| R-R-1956 | 200μg | 1300.00 | + Add to cart |
|
|
|
||||
Product description
Loncastuximab tesirine/CAS No.1879918-31-6 is a human cluster of differentiation 19 (CD19)-directed antibody-drug conjugate (ADC). Once bound to CD19 on the cell membrane, loncastuximab tesirine is rapidly internalised and triggers cell death. Loncastuximab tesirin induces cell apoptosis, it can be used for the research of diffuse large B-cell lymphoma.
| Appearance | N/A |
|---|---|
| Molecular Weight | N/A |
| Purity | >90% |
| CAS | 1879918-31-6 |
| Synonyms | Loncastuximab tesirine-lpyl; ADCT-402 |
| Storage | -20℃, protected from light and moisture |
| Transportation | 4-25℃ temperature for up to 2 weeks |
| Stability | 1 year |
Document
Related Product

Items-$0.00

Email:
Tel.:
msds of Loncastuximab tesirine CAS No.1879918-31-6
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


